Most Popular Articles

1 2 3 4 5

Development of a Diagnostic Programmed Cell Death 1-Ligand 1 Immunohistochemistry Assay for Nivolumab Therapy in Melanoma

Phillips, Therese; Millett, Molly M.; Zhang, Xiaoling; More

Applied Immunohistochemistry & Molecular Morphology. 26(1):6-12, January 2018.

Immunohistochemical Performance of Estrogen and Progesterone Receptor Antibodies on the Dako Omnis Staining Platform: Evaluation in Multicenter Studies

Hicks, David; Dell’Orto, Patrizia; Falzon, Mary; More

Applied Immunohistochemistry & Molecular Morphology. 25(5):313-319, May/June 2017.

Clinicopathologic Characteristics of Microsatellite Instable Gastric Carcinomas Revisited: Urgent Need for Standardization

Mathiak, Micaela; Warneke, Viktoria S.; Behrens, Hans-Michael; More

Applied Immunohistochemistry & Molecular Morphology. 25(1):12-24, January 2017.

Development of a Companion Diagnostic PD-L1 Immunohistochemistry Assay for Pembrolizumab Therapy in Non–Small-cell Lung Cancer

Roach, Charlotte; Zhang, Nancy; Corigliano, Ellie; More

Applied Immunohistochemistry & Molecular Morphology. 24(6):392-397, July 2016.

BRAF and NRAS Mutations are Heterogeneous and Not Mutually Exclusive in Nodular Melanoma

Chiappetta, Caterina; Proietti, Ilaria; Soccodato, Valentina; More

Applied Immunohistochemistry & Molecular Morphology. 23(3):172-177, March 2015.

Human Papillomavirus (HPV) Detection in Cytologic Specimens: Similarities and Differences of Available Methodology

Bihl, Michel P.; Tornillo, Luigi; Kind, André B.; More

Applied Immunohistochemistry & Molecular Morphology. 25(3):184-189, March 2017.

Detecting Gene Rearrangements in Patient Populations Through a 2-Step Diagnostic Test Comprised of Rapid IHC Enrichment Followed by Sensitive Next-Generation Sequencing

Murphy, Danielle A.; Ely, Heather A.; Shoemaker, Robert; More

Applied Immunohistochemistry & Molecular Morphology. 25(7):513-523, August 2017.

1 2 3 4 5